An approach to help differentiate postinfarct scar from borderzone tissue using Ripple Mapping during ventricular tachycardia ablation.
Dibbendhu Khanra, Peter Calvert, Susan Hughes...
https://pubmed.ncbi.nlm.nih.gov/36478627/Actively Recruiting
Led by Liverpool Heart and Chest Hospital NHS Foundation Trust · Updated on 2026-10-08
40
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating a new technique called Dynamic Voltage Mapping to improve catheter ablation treatment for people with ventricular tachycardia VT, a dangerous heart rhythm disorder often linked to heart attacks or damage. VT arises from abnormal electrical circuits near scar tissue in the heart, which can lead to sudden heart-related death. The study aims to see if this new mapping method can better identify the scar and critical tissue to guide ablation and reduce VT recurrence. Participants will be randomly assigned to one of two groups one group will have Dynamic Voltage Maps available to the cardiologist during ablation procedures, while the other will receive the standard catheter ablation without access to these maps. Ablation involves threading catheters through blood vessels to the heart to destroy abnormal circuits using heat, freezing, or electrical energy. The study plans to include 40 participants undergoing VT ablation. During the study, participants will be monitored from enrollment through one year after the procedure. Researchers will assess procedure details such as total time, ablation time, and the number of lesions applied, as well as immediate success in stopping VT and the rate of VT recurrence over 12 months. The study will also evaluate overall feasibility. Participants can expect thorough follow-up to measure these outcomes and ensure safety throughout the trial period.
CONDITIONS
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia Substrate
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Liverpool Heart and Chest Hospital NHS Foundation Trust
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo catheter ablation for ventricular tachycardia, guided either by Dynamic Voltage Mapping or standard care depending on their assigned group.
1 procedure visit
Duration - 12 months
Participants are monitored for up to 12 months after the procedure to assess procedure success, ventricular tachycardia recurrence, and safety.
Regular follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Dibbendhu Khanra, Peter Calvert, Susan Hughes...
https://pubmed.ncbi.nlm.nih.gov/36478627/Mark T Mills, Peter Calvert, Justin Chiong...
https://pubmed.ncbi.nlm.nih.gov/39507206/Joao Grade Santos, Mark T Mills, Peter Calvert...
https://pubmed.ncbi.nlm.nih.gov/38690145/Liverpool Heart and Chest Hospital NHS Foundation Trust
Lead Sponsor